23.39k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|The Fight Against COVID19||+5.77%||-||-||-|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|JNJ||Johnson & Johnson||181.09||+1.63||+0.91%||4:00 p.m. EDT||5.85M||7.62M||476.52B|
|PFE||Pfizer Inc.||53.91||-0.08||-0.15%||4:03 p.m. EDT||21.00M||27.27M||302.48B|
|ABBV||AbbVie Inc.||150||-0.57||-0.38%||4:03 p.m. EDT||8.25M||7.34M||267.51B|
|SNY||Sanofi||55.15||-0.35||-0.63%||4:00 p.m. EDT||3.65M||2.28M||138.10B|
|GSK||GSK plc||44.06||-0.36||-0.81%||4:00 p.m. EDT||5.72M||5.27M||112.19B|
|GILD||Gilead Sciences, Inc.||64.8||+0.33||+0.51%||4:00 p.m. EDT||6.44M||9.41M||81.96B|
|REGN||Regeneron Pharmaceuticals, Inc.||692.8||+9.36||+1.37%||4:00 p.m. EDT||558.69k||644.75k||76.93B|
|MRNA||Moderna, Inc.||147.66||+11.86||+8.73%||4:00 p.m. EDT||7.54M||6.88M||58.73B|
|TAK||Takeda Pharmaceutical Company Limited||14.77||-0.07||-0.47%||4:00 p.m. EDT||1.40M||2.55M||46.16B|
|BNTX||BioNTech SE||166.96||+8.81||+5.57%||4:00 p.m. EDT||1.07M||1.55M||40.57B|
|NVAX||Novavax, Inc.||55.29||+8.22||+17.46%||4:00 p.m. EDT||7.48M||4.68M||4.32B|
|VIR||Vir Biotechnology, Inc.||26.7||+2.24||+9.16%||4:00 p.m. EDT||871.56k||1.65M||3.53B|
|INO||Inovio Pharmaceuticals, Inc.||1.99||+0.24||+13.71%||4:00 p.m. EDT||10.58M||5.84M||455.79M|
In this article, we discuss 10 small-cap stocks to sell now before recession begins. If you want to read about some more small-cap stocks to sell now before recession begins, go directly to 5 Small-Cap Stocks to Sell Now Before Recession Begins. The United States Department of Commerce released new economic numbers on May 27, […]
United Airlines headlines five stocks to watch for the week ahead. All are breaking resistance as the stock market rebounds.
Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time. More quarantine time "is not a crowd-pleaser," Dr. Sandra Kemmerly, an infectious disease specialist at Ochsner Health in New Orleans, told Reuters. Use of Pfizer's Paxlovid, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared as infections have risen.